Adding to the complexity, administration of plerixafor in a model of LPS-induced endotoxemia resulted in enhanced serum levels of TNF, IFN-γ and NO levels and overall worsened outcomes [46]. This evidence concerns the gene IFNG and serum lipopolysaccharide activity.